These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20802486)

  • 1. Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance.
    Wohlkonig A; Chan PF; Fosberry AP; Homes P; Huang J; Kranz M; Leydon VR; Miles TJ; Pearson ND; Perera RL; Shillings AJ; Gwynn MN; Bax BD
    Nat Struct Mol Biol; 2010 Sep; 17(9):1152-3. PubMed ID: 20802486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions.
    Aldred KJ; Schwanz HA; Li G; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N
    ACS Chem Biol; 2013 Dec; 8(12):2660-8. PubMed ID: 24047414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance.
    Aldred KJ; McPherson SA; Wang P; Kerns RJ; Graves DE; Turnbough CL; Osheroff N
    Biochemistry; 2012 Jan; 51(1):370-81. PubMed ID: 22126453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance.
    Aldred KJ; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N
    Nucleic Acids Res; 2013 Apr; 41(8):4628-39. PubMed ID: 23460203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridge.
    Aldred KJ; Breland EJ; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7182-7. PubMed ID: 25246407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases.
    Laponogov I; Sohi MK; Veselkov DA; Pan XS; Sawhney R; Thompson AW; McAuley KE; Fisher LM; Sanderson MR
    Nat Struct Mol Biol; 2009 Jun; 16(6):667-9. PubMed ID: 19448616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU.
    Liu YH; Kuo SC; Lee YT; Chang IC; Yang SP; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2012 Apr; 45(2):108-12. PubMed ID: 22153765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of the bacterial resistance to fluoroquinolones: a computational study.
    Lupala CS; Gomez-Gutierrez P; Perez JJ
    Curr Comput Aided Drug Des; 2013 Jun; 9(2):281-8. PubMed ID: 23106777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of a quinolone-stabilized cleavage complex of topoisomerase IV from Klebsiella pneumoniae and comparison with a related Streptococcus pneumoniae complex.
    Veselkov DA; Laponogov I; Pan XS; Selvarajah J; Skamrova GB; Branstrom A; Narasimhan J; Prasad JV; Fisher LM; Sanderson MR
    Acta Crystallogr D Struct Biol; 2016 Apr; 72(Pt 4):488-96. PubMed ID: 27050128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a pyrosequencing assay for rapid assessment of quinolone resistance in Acinetobacter baumannii isolates.
    Deccache Y; Irenge LM; Savov E; Ariciuc M; Macovei A; Trifonova A; Gergova I; Ambroise J; Vanhoof R; Gala JL
    J Microbiol Methods; 2011 Jul; 86(1):115-8. PubMed ID: 21514328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RuvAB branch migration complex can displace topoisomerase IV.quinolone.DNA ternary complexes.
    Shea ME; Hiasa H
    J Biol Chem; 2003 Nov; 278(48):48485-90. PubMed ID: 13679378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolones inhibit DNA religation mediated by Staphylococcus aureus topoisomerase IV. Changes in drug mechanism across evolutionary boundaries.
    Anderson VE; Zaniewski RP; Kaczmarek FS; Gootz TD; Osheroff N
    J Biol Chem; 1999 Dec; 274(50):35927-32. PubMed ID: 10585479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii.
    Vila J; Ruiz J; Goñi P; Jimenez de Anta T
    J Antimicrob Chemother; 1997 Jun; 39(6):757-62. PubMed ID: 9222045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.
    Pommier Y; Leo E; Zhang H; Marchand C
    Chem Biol; 2010 May; 17(5):421-33. PubMed ID: 20534341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Glu-84 of the ParC subunit plays critical roles in both topoisomerase IV-quinolone and topoisomerase IV-DNA interactions.
    Hiasa H
    Biochemistry; 2002 Oct; 41(39):11779-85. PubMed ID: 12269820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus.
    Robertson GT; Bonventre EJ; Doyle TB; Du Q; Duncan L; Morris TW; Roche ED; Yan D; Lynch AS
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2313-23. PubMed ID: 18443108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action.
    Heddle JG; Barnard FM; Wentzell LM; Maxwell A
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1249-64. PubMed ID: 11097055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates of Acinetobacter baumannii in China.
    Yang H; Hu L; Liu Y; Ye Y; Li J
    J Chemother; 2016 Oct; 28(5):443-5. PubMed ID: 25895829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of quinolone action. A drug-induced structural perturbation of the DNA precedes strand cleavage by topoisomerase IV.
    Marians KJ; Hiasa H
    J Biol Chem; 1997 Apr; 272(14):9401-9. PubMed ID: 9083078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP-bound conformation of topoisomerase IV: a possible target for quinolones in Streptococcus pneumoniae.
    Sifaoui F; Lamour V; Varon E; Moras D; Gutmann L
    J Bacteriol; 2003 Oct; 185(20):6137-46. PubMed ID: 14526026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.